28 results on '"Cianniello, Daniela"'
Search Results
2. PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in Italy
3. Neratinib as adjuvant therapy in patients with HER2 positive breast cancer: expert opinion
4. Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial results
5. Correction: Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial
6. Uptake of Trastuzumab Biosimilars for the Treatment of HER2-Positive Breast Cancer: A Real-World Experience from a Cancer Center
7. Quality of Life in Women Diagnosed with Breast Cancer after a 12-Month Treatment of Lifestyle Modifications
8. Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial
9. Targeting Cell Cycle in Breast Cancer: CDK4/6 Inhibitors
10. Progression-Free Survival and Overall Survival of CDK 4/6 Inhibitors Plus Endocrine Therapy in Metastatic Breast Cancer: A Systematic Review and Meta-Analysis
11. Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives
12. Gene Expression Assay in the Management of Early Breast Cancer
13. Effect of a low glycemic index Mediterranean diet on cardiovascular risk factors in women diagnosed with breast cancer: Preliminary data from DEDiCa study
14. Adherence to Mediterranean Diet and Quality of Life in women treated for breast cancer (DEDiCa Study)
15. Long-term toxicity profile of trastuzumab emtansine (T-DM1): A multicenter real-life study.
16. CDK 4/6 inhibitors (CDKi) + endocrine therapy (ET) in ER-positive metastatic breast cancer (mBC) patients according ET sensitivity: A systematic review and meta-analysis.
17. Patient with metastatic breast cancer, HER2-positive, trastuzumab- and pertuzumab-resistant responding to lapatinib: Paziente con carcinoma mammario metastatico, HER2-positivo, resistente a trastuzumab e pertuzumab ma responsivo a lapatinib
18. Patient with metastatic breast cancer, HER2-positive, trastuzumab- and pertuzumab-resistant responding to lapatinib
19. PerTe: Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancer patients—Efficacy and safety of pertuzumab in “real life" setting.
20. Eribulin as an effective monotherapy in a chemo-pretreated woman with metastatic breast cancer: a case report
21. Efficacy and safety of T-DM1 in the ‘common-practice’ of HER2+ advanced breast cancer setting: a multicenter study
22. Treatment of triple negative brest cancer (TNBC): current options and future perspectives
23. Impact of single/dual HER2 inhibition and chemotherapy (CT) backbone upon pathologic complete response (pCR) in patients receiving neoadjuvant CT for operable/locally advanced breast cancer (O/LABC): A treatment-interaction analysis of randomized trials.
24. PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in Italy
25. Gene expression assay in the management of early breast cancer
26. Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial results
27. Efficacy and safety of T-DM1 in the ‘common-practice’ of HER2+ advanced breast cancer setting: a multicenter study
28. Eribulin as an effective monotherapy in a chemo-pretreated woman with metastatic breast cancer: a case report
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.